Norges Bank’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $156K | Hold |
|
|||||
|
2023
Q2 | $150K | Hold |
|
|||||
|
2023
Q1 | $184K | Sell |
|
|||||
|
2022
Q4 | $3.83M | Hold |
|
|||||
|
2022
Q3 | $5.43M | Hold |
|
|||||
|
2022
Q2 | $6.45M | Buy |
|
|||||
|
2022
Q1 | $8.6M | Sell |
|
|||||
|
2021
Q4 | $23.9M | Buy |
|
|||||
|
2021
Q3 | $25.7M | Sell |
|
|||||
|
2021
Q2 | $31.1M | Sell |
|
|||||
|
2021
Q1 | $37.1M | Sell |
|
|||||
|
2020
Q4 | $37.3M | Hold |
|
|||||
|
2020
Q3 | $36.4M | Sell |
|
|||||
|
2020
Q2 | $54.3M | Sell |
|
|||||
|
2020
Q1 | $43.4M | Hold |
|
|||||
|
2019
Q4 | $52.5M | Sell |
|
|||||
|
2019
Q3 | $45.2M | Buy |
|
|||||
|
2019
Q2 | $81.1M | Buy |
|
|||||
|
2019
Q1 | $65.1M | Hold |
|
|||||
|
2018
Q4 | $63.7M | Buy |
|
|||||
|
2018
Q3 | $104M | Buy |
|
|||||
|
2018
Q2 | $80.2M | Buy |
|
|||||
|
2018
Q1 | $149M | Sell |
|
|||||
|
2017
Q4 | $145M | Sell |
|
|||||
|
2017
Q3 | $65.1M | Hold |
|
|||||
|
2017
Q2 | $53.1M | Buy |
|
|||||
|
2017
Q1 | $55.2M | Sell |
|
|||||
|
2016
Q4 | $31.6M | Buy |
|
|||||
|
2016
Q3 | $37.8M | Hold |
|
|||||
|
2016
Q2 | $32.8M | Hold |
|
|||||
|
2016
Q1 | $31.6M | Buy |
|
|||||
|
2015
Q4 | $36M | Hold |
|
|||||
|
2015
Q3 | $23.4M | Hold |
|
|||||
|
2015
Q2 | $26.7M | Hold |
|
|||||
|
2015
Q1 | $23.5M | Buy |
|
|||||
|
2014
Q4 | $26.4M | Buy |
|
|||||
|
2014
Q3 | $14.3M | Sell |
|
|||||
|
2014
Q2 | $24.1M | Buy |
|
|||||
|
2014
Q1 | $11.4M | Hold |
|
|||||
|
2013
Q4 | $10.6M | Sell |
|
|||||
|
2013
Q3 | $9.89M | Buy |
|
|||||
|
2013
Q2 | $8.89M | Buy |
|